Sirio Pharma Co., Ltd. (SHE:300791)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Vitamins & Nutrition Products	4.26B	4.21B	3.58B	2.51B	2.37B
Vitamins & Nutrition Products Growth	1.23%	17.56%	42.87%	5.84%	14.62%
Total	4.26B	4.21B	3.58B	2.51B	2.37B
Total Growth	1.23%	17.56%	42.87%	5.84%	14.62%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	1.71B	1.66B	1.85B	1.49B	1.46B
China Growth	3.26%	-10.28%	24.11%	2.28%	14.06%
Americas	1.55B	1.67B	1.04B	540.90M	398.08M
Americas Growth	-6.90%	59.56%	93.04%	35.88%	49.79%
Europe	755.30M	604.48M	529.11M	395.52M	435.36M
Europe Growth	24.95%	14.25%	33.78%	-9.15%	-5.68%
Other Areas	241.70M	279.95M	157.83M	79.48M	77.34M
Other Areas Growth	-13.67%	77.38%	98.56%	2.78%	26.66%
Total	4.26B	4.21B	3.58B	2.51B	2.37B
Total Growth	1.23%	17.56%	42.87%	5.84%	14.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error